Indivior PLC Form 4 insider transactions

Indivior Pharmaceuticals Director Mark Stejbach received a grant of 3,722 Restricted Stock Units, increasing his beneficial ownership to 20,569 shares.

Indivior Pharmaceuticals director Juliet Thompson was granted 3,722 Restricted Stock Units, increasing her beneficial ownership.

Indivior Pharmaceuticals, Inc. Director Keith Humphreys received a grant of 3,722 Restricted Stock Units, increasing his beneficial ownership.

INDIVIOR PLC Director Barbara Ryan acquired 775 ordinary shares at $35.3926 each through a non-executive director purchase plan.

Indivior PLC Director Keith Humphreys acquired 775 ordinary shares at $35.3926 each, increasing his direct beneficial ownership to 5,802 shares.

Indivior PLC Director Daniel A. Ninivaggi acquired 775 ordinary shares at $35.3926 each through a pre-arranged equity plan.

Indivior PLC Director Mark Stejbach acquired 775 ordinary shares at $35.3926 each through a pre-arranged non-executive director purchase plan.

Indivior PLC Director David E. Wheadon acquired 1,771 ordinary shares at $35.3926 each through a non-executive director purchase plan.